Showing 1 to 12 of 15 results
Brain Cancer Patient Aims to Break Marathon Fundraising Record
Iain Ward, a 36-year-old content creator with terminal brain cancer, is aiming to break the world record for most money raised by a marathon runner, currently £2.3 million, during the New York City Marathon in November.
Brain Cancer Patient Aims to Break Marathon Fundraising Record
Iain Ward, a 36-year-old content creator with terminal brain cancer, is aiming to break the world record for most money raised by a marathon runner, currently £2.3 million, during the New York City Marathon in November.
Progress
36% Bias Score
Glioblastoma Patient Shows No Signs of Cancer After Immunotherapy Treatment
A 43-year-old man, Ben Trotman, diagnosed with glioblastoma in October 2022, is cancer-free following an experimental immunotherapy treatment at University College London Hospital, defying the typical 12-18 month survival rate for this aggressive brain cancer.
Glioblastoma Patient Shows No Signs of Cancer After Immunotherapy Treatment
A 43-year-old man, Ben Trotman, diagnosed with glioblastoma in October 2022, is cancer-free following an experimental immunotherapy treatment at University College London Hospital, defying the typical 12-18 month survival rate for this aggressive brain cancer.
Progress
48% Bias Score
Misdiagnosis of Glioblastoma Leads to Terminal Diagnosis
A 61-year-old British woman, Fiona Charles, was misdiagnosed with a mini-stroke instead of glioblastoma, a lethal brain cancer, leading to a terminal diagnosis with only a year to live; her son is fundraising for brain tumor research due to the low research funding.
Misdiagnosis of Glioblastoma Leads to Terminal Diagnosis
A 61-year-old British woman, Fiona Charles, was misdiagnosed with a mini-stroke instead of glioblastoma, a lethal brain cancer, leading to a terminal diagnosis with only a year to live; her son is fundraising for brain tumor research due to the low research funding.
Progress
28% Bias Score
Michael Bolton Diagnosed with Glioblastoma, Focuses on Family Amidst Treatment
Singer Michael Bolton, 72, revealed his glioblastoma diagnosis in December 2023, undergoing two brain surgeries, radiation, and chemotherapy; he's now focused on family and cherishing time with his children.
Michael Bolton Diagnosed with Glioblastoma, Focuses on Family Amidst Treatment
Singer Michael Bolton, 72, revealed his glioblastoma diagnosis in December 2023, undergoing two brain surgeries, radiation, and chemotherapy; he's now focused on family and cherishing time with his children.
Progress
24% Bias Score
Optune's Delayed Funding Highlights Flaws in Canada's Drug Approval Process
Despite Health Canada's 2022 approval and a 2017 study showing Optune's effectiveness in extending the lives of glioblastoma patients, its \$27,000 monthly cost and lack of provincial funding create significant delays and inequities in access across Canada.
Optune's Delayed Funding Highlights Flaws in Canada's Drug Approval Process
Despite Health Canada's 2022 approval and a 2017 study showing Optune's effectiveness in extending the lives of glioblastoma patients, its \$27,000 monthly cost and lack of provincial funding create significant delays and inequities in access across Canada.
Progress
56% Bias Score
Brain Cancer Recurrence Prompts Clinical Trial
Professor Richard Scolyer, a 58-year-old Australian of the Year, faces potential recurrence of his aggressive brain cancer after a recent scan; surgery is scheduled for Monday to assess and potentially remove the tumor, though his prognosis remains 3-6 months, following an experimental treatment tha...
Brain Cancer Recurrence Prompts Clinical Trial
Professor Richard Scolyer, a 58-year-old Australian of the Year, faces potential recurrence of his aggressive brain cancer after a recent scan; surgery is scheduled for Monday to assess and potentially remove the tumor, though his prognosis remains 3-6 months, following an experimental treatment tha...
Progress
24% Bias Score
New Glioblastoma Therapy Shows Promise in Clinical Trial
A New Jersey woman, Pamela Goldberger, 65, diagnosed with glioblastoma in 2023, is alive and healthy 2.5 years later after participating in a clinical trial for a new individualized dendritic cell therapy (DOC1021), showing promising results for this aggressive cancer.
New Glioblastoma Therapy Shows Promise in Clinical Trial
A New Jersey woman, Pamela Goldberger, 65, diagnosed with glioblastoma in 2023, is alive and healthy 2.5 years later after participating in a clinical trial for a new individualized dendritic cell therapy (DOC1021), showing promising results for this aggressive cancer.
Progress
40% Bias Score
Fit Teacher Dies Days After Brain Tumor Diagnosis
51-year-old fit and healthy sports teacher Glenn Colmer died from a high-grade glioma brain tumor less than a week after diagnosis, highlighting the aggressive and often fatal nature of this cancer and the need for increased awareness and research funding.
Fit Teacher Dies Days After Brain Tumor Diagnosis
51-year-old fit and healthy sports teacher Glenn Colmer died from a high-grade glioma brain tumor less than a week after diagnosis, highlighting the aggressive and often fatal nature of this cancer and the need for increased awareness and research funding.
Progress
48% Bias Score
Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return
Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.
Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return
Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.
Progress
32% Bias Score
Oncolytic Virotherapy Shows Promise in Treating Recurrent Glioblastoma
Oncolytic viruses are demonstrating effectiveness in treating aggressive brain cancers like glioblastoma, with a Biotherapy International patient achieving remission after failing conventional treatments; this targeted approach, using the Omaya reservoir for precise drug delivery, offers improved ou...
Oncolytic Virotherapy Shows Promise in Treating Recurrent Glioblastoma
Oncolytic viruses are demonstrating effectiveness in treating aggressive brain cancers like glioblastoma, with a Biotherapy International patient achieving remission after failing conventional treatments; this targeted approach, using the Omaya reservoir for precise drug delivery, offers improved ou...
Progress
68% Bias Score
Brain Tumor Regrowth Leaves Former Australian of the Year with Months to Live
Former Australian of the Year Professor Richard Scolyer's aggressive brain tumor has regrown after multiple surgeries and experimental treatment, leaving him with a prognosis of months to live, despite exceeding typical survival rates by nine months; his case informs a world-first clinical trial for...
Brain Tumor Regrowth Leaves Former Australian of the Year with Months to Live
Former Australian of the Year Professor Richard Scolyer's aggressive brain tumor has regrown after multiple surgeries and experimental treatment, leaving him with a prognosis of months to live, despite exceeding typical survival rates by nine months; his case informs a world-first clinical trial for...
Progress
20% Bias Score
Mia Love's Family Shifts Focus to Spending Time With Her After Cancer Stops Responding to Treatment
Former U.S. Representative Mia Love, diagnosed with glioblastoma in 2022, is no longer responding to cancer treatment; her family is focusing on spending their remaining time with her. Love, the first Black Republican woman elected to Congress, served two terms (2014-2018) before losing her seat.
Mia Love's Family Shifts Focus to Spending Time With Her After Cancer Stops Responding to Treatment
Former U.S. Representative Mia Love, diagnosed with glioblastoma in 2022, is no longer responding to cancer treatment; her family is focusing on spending their remaining time with her. Love, the first Black Republican woman elected to Congress, served two terms (2014-2018) before losing her seat.
Progress
16% Bias Score
Showing 1 to 12 of 15 results